Takaya Ikeda

939 total citations
51 papers, 442 citations indexed

About

Takaya Ikeda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Takaya Ikeda has authored 51 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Takaya Ikeda's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Takaya Ikeda is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Takaya Ikeda collaborates with scholars based in Japan, United States and Taiwan. Takaya Ikeda's co-authors include Shingo Matsumoto, Masahiro Umeda, Souichi Yanamoto, Izumi Asahina, Shigeto Yamada, Kōichi Goto, Hiroyuki Yamaguchi, Kiyotaka Yoh, Shuichi Fujita and Minoru Fukuda and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Takaya Ikeda

49 papers receiving 438 citations

Peers

Countries citing papers authored by Takaya Ikeda

Since Specialization

Citations

This map shows the geographic impact of Takaya Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takaya Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takaya Ikeda more than expected).

Fields of papers citing papers by Takaya Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takaya Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takaya Ikeda. The network helps show where Takaya Ikeda may publish in the future.

Co-authorship network of co-authors of Takaya Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Takaya Ikeda. A scholar is included among the top collaborators of Takaya Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takaya Ikeda. Takaya Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fundamental Aspects of Wire Arc Additive Manufacturing for Aluminum Foams 2024 ·MATERIALS TRANSACTIONS ·Ryosuke O. Suzuki, Takaya Ikeda, Keishi Fujiwara, (unknown), Yoshihiko Hangai, Hidetoshi Fujii, S. Kobayashi	2
2	Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight 2023 ·Cancer Science ·Yutaka Fujiwara, (unknown), Tetsunari Hase, Naozumi Hashimoto, Tomoyuki Naito, Yukari Tsubata, (unknown), Toshiaki Takahashi, Haruki Kobayashi, Yuki Shinno, Yoshitaka Zenke, Takaya Ikeda, Yukio Hosomi, Kageaki Watanabe, Satoru Kitazono, (unknown), Yoshinori Makino, Noboru Yamamoto	7
3	Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia) 2023 ·Journal of Thoracic Oncology ·Tetsuya Sakai, Shingo Matsumoto, (unknown), Yuji Shibata, Takaya Ikeda, Atsushi Nakamura, Masahiro Kodani, Kadoaki Ohashi, Naoki Furuya, Hiroki Izumi, Kaname Nosaki, Shigeki Umemura, Yoshitaka Zenke, Hibiki Udagawa, Eri Sugiyama, Kiyotaka Yoh, Kōichi Goto	9
4	O7-3 Phase II study of brigatinib in patients with TKI-naive ROS1-rearranged non-small cell lung cancer (NSCLC): Barossa study 2023 ·Annals of Oncology ·Toshiaki Takahashi, Seiji Niho, Ryo Toyozawa, Yasushi Goto, Kadoaki Ohashi, Haruko Daga, Hiroshi Tanaka, Yoshihiro Hattori, Masahiro Morise, Jun Sakakibara‐Konishi, Masahiro Kodani, Takaya Ikeda, Shingo Matsumoto, Kiyotaka Yoh, Shogo Nomura, Kōichi Goto	1
5	977P Phase II study of brigatinib in patients with tyrosine kinase inhibitor (TKI)-naïve ROS1-rearranged advanced non-small cell lung cancer (NSCLC): Barossa cohort 1 2022 ·Annals of Oncology ·Ryo Toyozawa, Seiji Niho, (unknown), (unknown), Kadoaki Ohashi, (unknown), (unknown), (unknown), Masahiro Morise, Jun Sakakibara‐Konishi, (unknown), Takaya Ikeda, Shunya Matsumoto, Kiyotaka Yoh, Shusaku Nomura, Keiko Goto	1
6	Immune complexome analysis of serum samples from non-small-cell lung cancer patients identifies predictive biomarkers for nivolumab therapy 2022 ·Clinica Chimica Acta ·(unknown), Yoichi Nakamura, Takaya Ikeda, (unknown), (unknown), Tomoaki Kurosaki, (unknown), (unknown), Hiroo Nakagawa, Kayoko Sato, (unknown), Mihoko N. Nakashima, Mikiro Nakashima, Hiroshi Mukae, Kaname Ohyama	2
7	High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung 2021 ·Lung Cancer ·Akira Sugimoto, Shigeki Umemura, Tomohiro Miyoshi, Tokiko Nakai, (unknown), Kaname Nosaki, Takaya Ikeda, Hibiki Udagawa, Keisuke Kirita, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Masahiro Tsuboi, Kōichi Goto, Genichiro Ishii	3
8	Comparison of the efficiency of endobronchial ultrasound-guided transbronchial needle aspiration using a 22G needle versus 25G needle for the diagnosis of lymph node metastasis in patients with lung cancer: a prospective randomized, crossover study 2021 ·Translational Lung Cancer Research ·Tetsuya Sakai, Hibiki Udagawa, Keisuke Kirita, Shogo Nomura, Ryo Itotani, (unknown), Akira Sugimoto, (unknown), Tomoyuki Naito, Hiroki Izumi, Kaname Nosaki, Takaya Ikeda, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Tokiko Nakai, Genichiro Ishii, Kōichi Goto	7
9	Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK -Rearranged/ TP53 -Mutant NSCLC via Noxa Expression 2020 ·Clinical Cancer Research ·Azusa Tanimoto, Shingo Matsumoto, Shinji Takeuchi, Sachiko Arai, Koji Fukuda, Akihiro Nishiyama, Kiyotaka Yoh, Takaya Ikeda, Naoki Furuya, Kazumi Nishino, Yuichiro Ohe, Kōichi Goto, Seiji Yano	38
10	Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer 2020 ·Journal of Cancer Research and Clinical Oncology ·Tetsuya Sakai, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Kaname Nosaki, Takaya Ikeda, Yoshitaka Zenke, Keisuke Kirita, Seiji Niho, Tetsuo Akimoto, Kōichi Goto, Genichiro Ishii	4
11	Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study 2019 ·Thoracic Cancer ·Shinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, Takaya Ikeda, (unknown), (unknown), (unknown), (unknown), Hirokazu Taniguchi, (unknown), (unknown), Takeshi Kitazaki, Katsumi Nakatomi, Seiji Nagashima, Masaaki Fukuda, Akitoshi Kinoshita, Hiroshi Soda, Hiroshi Mukae	3
12	OA01.05 Cryobiopsy Compared with Forceps Biopsy in Pathological Diagnosis and Biomarker Research in Lung Cancer: A Prospective, Single-Arm Study 2019 ·Journal of Thoracic Oncology ·Tomoyuki Naito, Hibiki Udagawa, Keisuke Kirita, Takaya Ikeda, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Genichiro Ishii, Kōichi Goto	1
13	Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201) 2019 ·Lung Cancer ·Minoru Fukuda, Takeshi Kitazaki, (unknown), Masao Ichiki, Hiroshi Mukae, Riichiroh Maruyama, (unknown), Midori Shimada, Takaya Ikeda, Junji Kishimoto, Taishi Harada, Takashi Seto, Noriyuki Ebi, Koichi Takayama, Isamu Okamoto, Yukito Ichinose, Kenji Sugio	11
14	Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer 2019 ·Cancer Chemotherapy and Pharmacology ·Midori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, (unknown), (unknown), (unknown), Hirokazu Taniguchi, (unknown), (unknown), Shinnosuke Takemoto, Takaya Ikeda, Katsumi Nakatomi, Yoichi Nakamura, Seiji Nagashima, Takuya Yamazaki, Hiroshi Mukae	1
15	Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations 2016 ·Cancer Chemotherapy and Pharmacology ·(unknown), Yoichi Nakamura, Kazumi Sano, Shuntaro Sato, Yoji Ikegami, (unknown), Shinnosuke Takemoto, (unknown), (unknown), (unknown), Takaya Ikeda, Hiroyuki Yamaguchi, Katsumi Nakatomi, Minoru Fukuda, Koichi Izumikawa, Hiroshi Mukae	13
16	A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma 2015 ·International Journal of Oral and Maxillofacial Surgery ·Yuki Matsushita, Souichi Yanamoto, Hiroshi Takahashi, Shigeto Yamada, (unknown), Yuki Sakamoto, Hiroaki Ikeda, (unknown), Shuichi Fujita, Takaya Ikeda, Izumi Asahina, Masahiro Umeda	37
17	A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer 2014 ·Cancer Chemotherapy and Pharmacology ·(unknown), Takaya Ikeda, Minoru Fukuda, Yoichi Nakamura, Akitoshi Kinoshita, (unknown), Hirofumi Nakano, Takeshi Kitazaki, (unknown), Hirokazu Taniguchi, (unknown), Hiroyuki Yamaguchi, Katsumi Nakatomi, Midori Shimada, Seiji Nagashima, Kazuhiro Tsukamoto, Shigeru Kohno	4
18	Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma 2013 ·Clinical Lung Cancer ·(unknown), Yoichi Nakamura, Hiroyuki Yamaguchi, Takaya Ikeda, (unknown), (unknown), Seiji Doi, Katsumi Nakatomi, Tetsuya Iida, Tomayoshi Hayashi, Takeshi Nagayasu, Kazuhiro Tsukamoto, Shigeru Kohno	26
19	Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma 2012 ·International Journal of Oral and Maxillofacial Surgery ·Souichi Yanamoto, Shigeto Yamada, Hidenori Takahashi, Izumi Yoshitomi, Goro Kawasaki, H Ikeda, (unknown), Takuya Shiraishi, Shuichi Fujita, Takaya Ikeda, Izumi Asahina, Masahiro Umeda	73
20	Direct Comparison of 3 PCR Methods in Detecting EGFR Mutations in Patients with Advanced Non–Small-Cell Lung Cancer 2012 ·Clinical Lung Cancer ·Takaya Ikeda, Yoichi Nakamura, Hiroyuki Yamaguchi, (unknown), Seiji Doi, Katsumi Nakatomi, Tetsuya Iida, (unknown), (unknown), Takeshi Nagayasu, Kazuhiro Tsukamoto, Shigeru Kohno	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact